Characterization of Endothelial Progenitor Cell: Past, Present, and Future

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jul 27

PMID 35887039

Authors

Amankeldi A Salybekov

Shuzo Kobayashi

Takayuki Asahara

Affiliations

Soon will be listed here.

Abstract

Endothelial progenitor cells (EPCs) are currently being studied as candidate cell sources for revascularization strategies. Despite these promising results, widespread clinical acceptance of EPCs for clinical therapies remains hampered by several challenges. The challenges and issues surrounding the use of EPCs and the current paradigm being developed to improve the harvest efficiency and functionality of EPCs for application in regenerative medicine are discussed. It has been observed that controversies have emerged regarding the isolation techniques and classification and origin of EPCs. This manuscript attempts to highlight the concept of EPCs in a sequential manner, from the initial discovery to the present (origin, sources of EPCs, isolation, and identification techniques). Human and murine EPC marker diversity is also discussed. Additionally, this manuscript is aimed at summarizing our current and future prospects regarding the crosstalk of EPCs with the biology of hematopoietic cells and culture techniques in the context of regeneration-associated cells (RACs).

Citing Articles

Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury.

Wu D, Ma W, Wang L, Long C, Chen S, Liu J Mater Today Bio. 2025; 31:101528.

PMID: 39980630 PMC: 11840549. DOI: 10.1016/j.mtbio.2025.101528.

Stem Cell-Based Therapies via Different Administration Route for Stroke: A Meta-analysis of Comparative Studies.

Mulia G, Anna N, Wu J, Ma H, Chiang Y, Ou J Cell Transplant. 2025; 34:9636897251315121.

PMID: 39925239 PMC: 11808770. DOI: 10.1177/09636897251315121.

Stem cells and bio scaffolds for the treatment of cardiovascular diseases: new insights.

Razavi Z, Farokhi S, Mahmoudvand G, Karimi-Rouzbahani A, Farasati-Far B, Tahmasebi-Ghorabi S Front Cell Dev Biol. 2024; 12:1472103.

PMID: 39726717 PMC: 11669526. DOI: 10.3389/fcell.2024.1472103.

Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy.

Njoku G, Forkan C, Soltysik F, Nejsum P, Pociot F, Yarani R Bioact Mater. 2024; 45:41-57.

PMID: 39610953 PMC: 11602541. DOI: 10.1016/j.bioactmat.2024.11.004.

Recent advances in surface functionalization of cardiovascular stents.

Wang C, Lv J, Yang M, Fu Y, Wang W, Li X Bioact Mater. 2024; 44:389-410.

PMID: 39539518 PMC: 11558551. DOI: 10.1016/j.bioactmat.2024.10.025.

References

Fujisawa T, Tura-Ceide O, Hunter A, Mitchell A, Vesey A, Medine C . Endothelial Progenitor Cells Do Not Originate From the Bone Marrow. Circulation. 2019; 140(18):1524-1526. PMC: 6818974. DOI: 10.1161/CIRCULATIONAHA.119.042351. View

Fadini G, Losordo D, Dimmeler S . Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012; 110(4):624-37. PMC: 3382070. DOI: 10.1161/CIRCRESAHA.111.243386. View

Salybekov A, Salybekova A, Sheng Y, Shinozaki Y, Yokoyama K, Kobayashi S . Extracellular Vesicles Derived From Regeneration Associated Cells Preserve Heart Function After Ischemia-Induced Injury. Front Cardiovasc Med. 2021; 8:754254. PMC: 8564358. DOI: 10.3389/fcvm.2021.754254. View

Suzuki T, Nishida M, Futami S, Fukino K, Amaki T, Aizawa K . Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim. Cardiovasc Res. 2003; 58(2):487-92. DOI: 10.1016/s0008-6363(02)00780-0. View

Wakabayashi T, Naito H, Suehiro J, Lin Y, Kawaji H, Iba T . CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties. Cell Stem Cell. 2018; 22(3):384-397.e6. DOI: 10.1016/j.stem.2018.01.010. View

Rossi E, Poirault-Chassac S, Bieche I, Chocron R, Schnitzler A, Lokajczyk A . Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties. Stem Cell Rev Rep. 2019; 15(4):590-600. DOI: 10.1007/s12015-019-09881-8. View

Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere M . Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007; 27(7):1572-9. DOI: 10.1161/ATVBAHA.107.144972. View

Masuda H, Iwasaki H, Kawamoto A, Akimaru H, Ishikawa M, Ii M . Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med. 2012; 1(2):160-71. PMC: 3659679. DOI: 10.5966/sctm.2011-0023. View

Fadini G, Miorin M, Facco M, Bonamico S, Baesso I, Grego F . Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45(9):1449-57. DOI: 10.1016/j.jacc.2004.11.067. View

10.

Lacaud G, Kouskoff V . Hemangioblast, hemogenic endothelium, and primitive versus definitive hematopoiesis. Exp Hematol. 2017; 49:19-24. DOI: 10.1016/j.exphem.2016.12.009. View

11.

Losordo D, Kibbe M, Mendelsohn F, Marston W, Driver V, Sharafuddin M . A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv. 2012; 5(6):821-30. PMC: 3549397. DOI: 10.1161/CIRCINTERVENTIONS.112.968321. View

12.

Jiang L, Chen T, Sun S, Wang R, Deng J, Lyu L . Nonbone Marrow CD34 Cells Are Crucial for Endothelial Repair of Injured Artery. Circ Res. 2021; 129(8):e146-e165. DOI: 10.1161/CIRCRESAHA.121.319494. View

13.

Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

14.

Friedrich E, Walenta K, Scharlau J, Nickenig G, Werner N . CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 2006; 98(3):e20-5. DOI: 10.1161/01.RES.0000205765.28940.93. View

15.

Masuda H, Rica Tanaka , Fujimura S, Ishikawa M, Akimaru H, Shizuno T . Vasculogenic conditioning of peripheral blood mononuclear cells promotes endothelial progenitor cell expansion and phenotype transition of anti-inflammatory macrophage and T lymphocyte to cells with regenerative potential. J Am Heart Assoc. 2014; 3(3):e000743. PMC: 4309104. DOI: 10.1161/JAHA.113.000743. View

16.

Masuda H, Alev C, Akimaru H, Ito R, Shizuno T, Kobori M . Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res. 2011; 109(1):20-37. DOI: 10.1161/CIRCRESAHA.110.231837. View

17.

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

18.

Salybekov A, Masuda H, Miyazaki K, Sheng Y, Sato A, Shizuno T . Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice. PLoS One. 2019; 14(3):e0205477. PMC: 6424405. DOI: 10.1371/journal.pone.0205477. View

19.

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

20.

Case J, Mead L, Bessler W, Prater D, White H, Saadatzadeh M . Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007; 35(7):1109-18. DOI: 10.1016/j.exphem.2007.04.002. View